GSK to invest $800 million in US to double capacity at Marietta facility
GSK Plc., will invest $800 million in its manufacturing facility in the US — the largest investment to date in the country — to
GSK Plc., will invest $800 million in its manufacturing facility in the US — the largest investment to date in the country — to
A clinical-stage US gene-editing company, Precision BioSciences, got approval from the Eastern European country of Moldova to start an in vivo human trial
Multiple US agencies are investigating an outbreak of E. coli in the country, which was reported after eating Quarter Pounders hamburgers at McDonald’s,
HQ Team October 25, 2024: Researchers at the University of Waterloo have unveiled a nanomedicine that can deliver an entire course of antibiotics
HQ Team October 2, 2024: A device named Bioelectronic Localized Antimicrobial Stimulation Therapy (BLAST) has been developed to prevent skin infections by using harmless electrical
HQ Team October 25, 2024: A recent study indicates that a new slow-release ketamine pill could offer a promising alternative for individuals suffering
Bharti Jayshankar October 24, 2024: A recent study from New York University (NYU) Grossman School of Medicine has sparked renewed interest in the
Bharti Jayshankar October 24, 2024: In a Finnish population-based cohort study, researchers have found that mothers with a history of eating disorders or
Modifi Biosciences, Inc., a Yale University spinout company formed in 2021, has been acquired by Merck & Co. for about $1.3 billion to
Samsung Biologics has announced a $1.24 billion manufacturing deal with an unnamed Asian pharmaceutical company.